MICROBOT MEDICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
MICROBOT MEDICAL INC. (MBOT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.62% for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2020-11-16
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 1.20%, a 26.83% decline year-over-year.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 1.64%, a 31.38% decline year-over-year.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2018-03-31 was 2.39%.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.39%, a 45.73% increase from fiscal 2017.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 1.64%, a 173.33% increase from fiscal 2016.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2016 was 0.60%, a 40.00% decline from fiscal 2015.
- MICROBOT MEDICAL INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 1.00%, a 23.08% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | 1.62% 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | 1.20% 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | 1.20% 10-Q · filed 2020-05-15 | ||||
| 2019-09-30 | 1.64% 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | 1.64% 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 1.64% 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 2.39% 10-K · filed 2020-04-14 | ||||
| 2018-09-30 | 2.39% 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | 2.39% 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | 2.39% 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | 1.64% 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | 1.50% 10-Q · filed 2017-11-14 | ||||
| 2016-12-31 | 0.60% 10-K · filed 2018-04-02 | ||||
| 2015-12-31 | 1.00% 10-K · filed 2017-03-21 | 1.80% 10-K · filed 2016-03-15 | |||
| 2014-12-31 | 1.30% 10-K · filed 2016-03-15 | ||||
| 2013-12-31 | 1.20% 10-K · filed 2016-03-15 | ||||
| 2012-12-31 | 1.40% 10-K · filed 2015-03-13 | ||||
| 2011-12-31 | 2.70% 10-K · filed 2014-03-13 | ||||
| 2010-12-31 | 2.90% 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |